Skip to main content
. 2017 Dec 19;12(12):e0189990. doi: 10.1371/journal.pone.0189990

Table 3. Characterization of FRDA patients.

Patient Age of Onset (years) Interval between I and II a
F10 11 7 y, 9 mo
F11 14 7 y, 4 mo
F12 20 8 y, 3 mo
M7 10 8 y, 8 mo
F13 16 7 y, 4 mo

a Repeated blood samplings (I and II) were performed at the intervals indicated in the table.